The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Marinus Pharmaceuticals, Inc(NASDAQ:MRNS) 
Marinus Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing and commercializing therapeutics to treat rare seizure disorders. Its clinical stage product candidate, ganaxolone, is an allosteric modulator of GABAA, developed in formulations for two routes, including i...
Website: http://www.marinuspharma.com
Founded: 2003
Full Time Employees: 65
Sector: Healthcare
Industry: Biotechnology
Marinus Pharmaceuticals Days Payable Outstanding ttm (DPO)
Marinus Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Marinus Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Marinus Pharmaceuticals Op Cashflow Per Share ttm
Marinus Pharmaceuticals Free Cashflow Per Share ttm
Marinus Pharmaceuticals Cash Per Share ttm
Marinus Pharmaceuticals P/S ratio ttm
Marinus Pharmaceuticals (GAAP) P/E ratio ttm
Marinus Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.